sporty investor
06 Jun 2017
Reason/s for drop? Anything Negative?
Kuznetsov
23 Mar 2017
Re: SP Thanks for your view TS, I was worried something could have gone awry in US, but absence of big trades now seems reassuring and hopefully more likely indicates settling at new sp levels.Cheers Kuz
TOFFEESAINT
22 Mar 2017
Re: SP Just technical IMHO. V strong run recently, probably overbought.Shares characteristically fall quite heavily between news or results. Market makers working to stimulate activity.
Kuznetsov
22 Mar 2017
SP Any informed opinion about this mornings 11% share price dive would be greatly appreciated. Thanks KUZ
TOFFEESAINT
20 Mar 2017
NHS use can grow, then there's the US We use the disinfectant in our hospital.A peer -reviewed article from Australia was circulated last month, drawing attention to the risk of spores infecting ultrasound probes. (Just before the Aus licence was granted!)Tristel products are more expensive than a quick wipe with an alcohol rag but what would you want inserted into a delicate area??I know they are NOT used in 2 local hospitals so the market is far from saturated at home.The big game-changer will be a US Licence (please Mr Trump)I don't get in very often at the beginning of a growth story but this may be one (competition barring a cheaper effective alternative)
pharmaspecialist
23 Feb 2017
Overseas expansion going well As a shareholder, I was very pleased with these results, particularly because of the rapidly increasing overseas sales. The next market to crack is of course the most valuable one (the US) and major success in this market would be transformative. The company's technology has been rigorously validated but there may nevertheless be delays in US sales as the company needs to jump through the hoops of the US regulatory system. I am sure the company has a Plan B in the event of any undue delays, such as forming a partnership with a potential US competitor or, bearing in mind the size of the US market, even selling out to a US major. However, I would much prefer the company to continue global expansion itself.
equity_dev
01 Feb 2017
Interim results webinar - 23rd Feb If you would like to hear management present the interim results for Tristel we will be hosting a webinar on Thursday 23rd February at 12.15pm. Paul Swinney, Chief Executive, and Liz Dixon, Finance Director, will give a presentation lasting approximately 30 mins and there will then be an opportunity for Q&A.To join please register at: [link] you would like to submit any questions for management ahead of the meeting please send them to [email protected] regards,The Equity Development Team
II Editor
02 Dec 2016
NEW ARTICLE: The curse of the growth investor "LSE:TSTL:Tristel is perhaps unusual among smaller companies in publishing precise financial targets up to three years into the future. There's a danger that investors take them as a given, or extrapolate from them, even though they have yet to be ..."[link]
II Editor
11 Nov 2016
NEW ARTICLE: Share Sleuth: five rules for the rational investor " In recent months I've been reducing the number of criteria I use to judge an investment, and ensuring they are distinct from each other. The result is a template for what is, in my view, the perfect long-term investment. It should help me find ..."[link]
Callun
25 Oct 2016
Re: Huge spread & sp falling Hi missmolly,Present spread is showing 5p, which is quite normal for TSTL. You may find that if you set up a dummy trade you will be offered better prices. I find the actual buy/sellprices are usually much closer than those shown on ii, so a smaller spread.The SP has risen very strongly over the last month or so leading up to the results announcement last week. Results were expected to be good, and they didn't disappoint, being ahead of expectations. However, they did not drive the SP any further and I would expect latecomers to be taking profits.IMHO, this is a well run company with good prospects and an open and approachable management. Once they get their US approvals this should further enhance their export potential and I would anticipate further upward progress in the SP. However, that's my opinion, not advice, and DYOR applies of course.One final point about SP movement; it does have a habit of spiking down, only to return to the previous range, or better, reasonably quickly. It's up to the individual to consider if any such event presents a buying opportunity or a change of direction.Callun
missmolly
24 Oct 2016
Huge spread & sp falling Hi all,I wonder if anyone has views on why the spread is so large and also why the share price is falling over the past little while.Any other comments on the state of the company right now and future prospects would be very welcome.Good luck all holders!
equity_dev
20 Oct 2016
Re: Webinar with management A recording of Tuesday's webinar is now available at: [link] Equity Development team
equity_dev
28 Sep 2016
Webinar with management If you would like to hear management present the results for Tristel we will be hosting a webinar on Tuesday 18th October at 12.30pm. Paul Swinney, Chief Executive, and Liz Dixon, Finance Director, will give a presentation lasting approximately 30 mins and there will then be an opportunity for Q&A.To join please register at: [link] you would like to submit any questions for management ahead of the meeting please send them to [email protected] regards,The Equity Development Team
Callun
01 Aug 2016
Open day Did anyone here go to the open day last month? Unable to get there myself.I would appreciate any impressions, comments or opinions you might have gained from the visit if you can spare the time to share.ThanksCallun
SundayTrader
22 Jul 2016
Re: Trading update I am impressed with management here, despite the fiasco over the stock options last year. I will be sticking with my current holding.
